D. Peiffert

8.7k total citations · 2 hit papers
258 papers, 5.9k citations indexed

About

D. Peiffert is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, D. Peiffert has authored 258 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 106 papers in Surgery and 81 papers in Oncology. Recurrent topics in D. Peiffert's work include Advanced Radiotherapy Techniques (57 papers), Colorectal and Anal Carcinomas (47 papers) and Head and Neck Cancer Studies (39 papers). D. Peiffert is often cited by papers focused on Advanced Radiotherapy Techniques (57 papers), Colorectal and Anal Carcinomas (47 papers) and Head and Neck Cancer Studies (39 papers). D. Peiffert collaborates with scholars based in France, Spain and United Kingdom. D. Peiffert's co-authors include Andrés Cervantes, Rob Glynne‐Jones, C. Aschele, Vicky Goh, Dirk Arnold, Per J. Nilsson, Jean-François Bosset, M. Piérart, F. Eschwège and M. van Glabbeke and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

D. Peiffert

240 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

1997 898 citations D. Peiffert et al. profile →
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

2014 386 citations Rob Glynne‐Jones, D. Peiffert et al. profile →

Peers

Countries citing papers authored by D. Peiffert

Since Specialization

Citations

This map shows the geographic impact of D. Peiffert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Peiffert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Peiffert more than expected).

Fields of papers citing papers by D. Peiffert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Peiffert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Peiffert. The network helps show where D. Peiffert may publish in the future.

Co-authorship network of co-authors of D. Peiffert

This figure shows the co-authorship network connecting the top 25 collaborators of D. Peiffert. A scholar is included among the top collaborators of D. Peiffert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Peiffert. D. Peiffert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CyberKnife® stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?—a cohort study 2023 ·Journal of Thoracic Disease ·(unknown), Julia Salleron, V. Marchesi, D. Peiffert, (unknown), Jean Faivre	2
2	Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results 2023 ·Cancer/Radiothérapie ·Jérémie Jacques, Sophie Renard, (unknown), Jean Faivre, D. Peiffert	3
3	Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases? 2023 ·Cancer/Radiothérapie ·(unknown), Julia Salleron, Guillaume Vogin, (unknown), Pedro G. Teixeira, Sophie Colnat‐Coulbois, (unknown), S. Thureau, S. Supiot, D. Peiffert, G. Oldrini, (unknown)	1
4	A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization 2021 ·Clinical Cancer Research ·(unknown), Mamadou Diop, (unknown), Gilles Dolivet, Frédéric Marchal, C. Charra-Brunaud, D. Peiffert, (unknown), Birama Dembélé, (unknown), (unknown), (unknown), Agnès Leroux, Jean‐Louis Merlin, Halimatou Diop‐Ndiaye, Jean‐Marc Costa, Julia Salleron, Alexandre Harlé	28
5	Interstitial multi-catheter breast brachytherapy: Technical aspects and experience feedback in a comprehensive cancer center 2021 ·Cancer/Radiothérapie ·(unknown), Sophie Renard, Julia Salleron, (unknown), C. Charra-Brunaud, D. Peiffert	2
6	La radiothérapie stéréotaxique peut-elle remplacer la curiethérapie pour les cancers du col utérin localement évolués ? Positionnement de la Société française de radiothérapie oncologique 2020 ·Cancer/Radiothérapie ·Cyrus Chargari, Sophie Renard, Sophie Espenel, Alexandre Escande, (unknown), Anne Ducassou, D. Peiffert, (unknown)	7
7	Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC) 2019 ·European Journal of Cancer ·Eleonor Rivin del Campo, Oscar Matzinger, Karin Haustermans, D. Peiffert, Rob Glynne‐Jones, Kathryn Winter, André Konski, Jaffer A. Ajani, J.F. Bosset, Jean‐Michel Hannoun‐Lévi, Marc Puyraveau, A. Bapsi Chakravarthy, Helen Meadows, John Northover, Laurence Collette, Melissa Christiaens, P. Maingon	7
8	NHL-ChirEx: An interprofessional cross-border education initiative in the Greater Region with a focus on radiation morbidity and patient safety 2018 ·Radiotherapy and Oncology ·Guillaume Vogin, Jochen Fleckenstein, Jean‐Christophe Servotte, P. Nickers, (unknown), (unknown), Isabelle Bragard, Philippe Coucke, M. Untereiner, D. Peiffert, Marc Braun	2
9	Radiothérapie stéréotaxique hypofractionnée des métastases cérébrales : bénéfice de l’irradiation encéphalique totale ? 2017 ·Cancer/Radiothérapie ·P. Royer, Julia Salleron, Guillaume Vogin, Luc Taillandier, Christelle Clément-Duchêne, Olivier Klein, Jean Faivre, D. Peiffert, V. Bernier	1
10	Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study) 2017 ·Annals of Oncology ·Stéfano Kim, Éric François, (unknown), Emmanuelle Samalin, Farid El Hajbi, Nabil Baba-Hamed, Sarah Dumont, Simon Pernot, D. Peiffert, François Ghiringhelli, Olivier Bouché, Jérôme Desrame, Mustapha Zoubir, Aurélie Parzy, Denis Smith, Christelle de la Fouchardière, Bruno Buecher, V. Vendrely, Franck Bonnetain, Christophe Borg	1
11	High dose rate brachytherapy with customized applicators for malignant facial skin lesions 2016 ·Cancer/Radiothérapie ·R. Jumeau, (unknown), (unknown), (unknown), G. Oldrini, Guillaume Vogin, D. Peiffert	27
12	Efficacité et sécurité de la technique de radiothérapie mammaire avec complément d’irradiation concomitant : analyse de 121 cas traités à l’institut de cancérologie de Lorraine 2014 ·Cancer/Radiothérapie ·(unknown), C. Marchal, (unknown), Valentin Harter, D. Peiffert	3
13	Arrêt de la commercialisation des fils d’iridium 192 en France : proposition du groupe de curiethérapie de la Société française de radiothérapie oncologique 2014 ·Cancer/Radiothérapie ·D. Peiffert, Jean‐Michel Hannoun‐Lévi, (unknown), (unknown)	10
14	Radiothérapie conformationnelle avec modulation d’intensité dans les cancers de la sphère ORL : éthique et sélection des patients 2012 ·Cancer/Radiothérapie ·(unknown), (unknown), (unknown), P. Gräff, V. Marchesi, D. Peiffert	4
15	Contrôle de qualité en curiethérapie de débit de dose pulsé 2009 ·Cancer/Radiothérapie ·(unknown), Pascal Meyer, (unknown), D. Peiffert	2
16	Résultats préliminaires de l’étude STIC PDR intitulée « Utilisation de la curiethérapie pulsée gynécologique (PDR) avec optimisation de la répartition de la dose et dosimétrie tridimensionnelle » pour les cancers du col utérin 2008 ·Cancer/Radiothérapie ·C. Charra-Brunaud, D. Peiffert	9
17	Interstitial brachytherapy for invasive bladder carcinomas. The Nancy experience 1998 ·Cancer/Radiothérapie ·S. Hoffstetter, (unknown), D. Peiffert, (unknown), (unknown), M Pernot, Jacques Hubert	0
18	Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study 1997 ·Annals of Oncology ·D. Peiffert, Jean‐François Seitz, P. Rougier, Éric François, F. Cvitkovic, X. Mirabel, (unknown), Michel Ducreux, Jean‐Michel Hannoun‐Lévi, A. Lusinchi, (unknown), Thierry Conroy, Jean‐Pierre Pignon, J.P. Gérard	46
19	Etude statistique d'une serie de 672 carcinomes du col uterin. Resultats et complications selon l'age et les modalites de traitement 1995 ·Bulletin du Cancer ·M Pernot, S. Hoffstetter, D. Peiffert, (unknown), François Guillemin, Jean-Luc Verhaeghe, C. Marchal, É. Luporsi, V. Beckendorf, J Stinès, P. Aletti, (unknown), A. Lesur, Pierre Bey	12
20	Standards, options et recommandations pour une bonne pratique en radiothérapie externe et en curiethérapie en cancérologie 1995 ·Bulletin du Cancer ·Pierre Bey, G. Gaboriaud, D. Peiffert, P. Aletti, Jean‐Marc Cosset	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact